CLINICAL_TRIALS
withdrawal
· 2024-12-12
Clinical Trial Update: Ivabradine in Stage D Heart Failure Patients on Chronic Inotropes [Phase 4]
Summary
The Phase 4 Ivabradine trial in Stage D heart failure patients on chronic inotropes has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Maryland, Baltimore | Conditions: Heart Failure NYHA Class IV | Phase 4 | Status: WITHDRAWN